
Application YC di XGenomes
XGenomes ha partecipato a Y Combinator nel batch Winter 2019 come azienda Healthcare. Sotto: cosa fa l'azienda, chi l'ha fondata e la sua application a YC, ricostruita domanda per domanda nel form reale di YC.
- Batch YC
- Winter 2019
- Settore
- HealthcareDiagnostics
- Dimensione team
- 6
- Stato
- Active
- Lanciata
- 2018
Founder
Kalim MirFounder/CEO
Cosa fa XGenomes
At XGenomes, we are building a technology comprising novel biochemistry, hardware and algorithms for sequencing DNA. Our product will be streamlined: there is zero library preparation; we sequence directly on unadulterated single molecules of DNA; DNA extraction will be integrated with sequencing; there is no bioinformatics bottleneck. The sequence we produce will be of unprecedented accuracy due to several layers of in-built redundancy including the sequencing both strands of the double-helix concurrently. The sequence we produce will be complete, encompassing: structural as well as single nucleotide variants; long-range haplotype phase; the repetitive "dark matter" of the genome. The cost of goods (consumables) of sequencing will be <$10, which will allow us to price our product at a level that will help grow the market while still achieving >90% margin. We will start by offering access as a service to high value customers, which be followed by a razor and blade model of selling instruments and consumables.
Application YC di XGenomes, ricostruita
Domanda per Y Combinator
XGenomes, batch Winter 2019. Le vere domande del form, risposte da dati pubblici.
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
XGenomes
Building the sequencing technology of the future
We are building a DNA sequencing platform that sequences directly on unmodified single DNA molecules, with zero library preparation. Our technology integrates DNA extraction with sequencing and reads both strands simultaneously for high accuracy. It produces complete sequences covering structural variants and repetitive regions that current methods miss, and aims to lower consumable costs below $10.
We live and work in Boston and Cambridge, MA, and plan to keep the company based here after YC.
We chose Boston and Cambridge because of the rich biotech ecosystem and access to top scientific and engineering talent needed for developing novel sequencing technology.
21 risposte in più nell'application completa
Founders, Progress, Idea, Equity, Curious, Batch Preference sono nella versione completa. Crea un account gratuito per aprirla in YC Insights, accanto a ogni altro batch YC.
Domande Frequenti
Questa è l'application YC reale di XGenomes?
No. Y Combinator mantiene private le application inviate. Questa è una ricostruzione: le domande del form YC reale, a cui si è risposto usando i dati pubblici di XGenomes (note di lancio, background dei founder, descrizione del prodotto). Mostra come un'azienda come XGenomes si presenterebbe a YC, non il testo che hanno inviato.
A quale batch YC apparteneva XGenomes?
XGenomes apparteneva al batch Winter 2019 di Y Combinator.
Chi ha fondato XGenomes?
XGenomes è stato fondato da Kalim Mir.
Cosa fa XGenomes?
XGenomes is building the sequencing technology of the future.
Come leggo la ricostruzione completa della application?
Crea un account Round Funded gratuito. La versione completa di 26 risposte della application di XGenomes, e di ogni altro batch YC, è in YC Insights.